CD4 and central nervous system cancer: Directly comparing ALE with IDH-WT glioma, activated CD4+ Tc were even higher in IDH-WT glioma than in ALE patients (Fig. 1B, H, R), whereas CD4+ were elevated in the PB of ALE patients (Fig. 1B, G).